Industry: Medical Devices & Consumables
Published Date: 2024-06-15
Pages: 147 Pages
Report ld: 3201716
Request Sample
Customized Report
In vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. Generally speaking, this method can be divided in two key areas: anatomical/morphological imaging and molecular imaging. In molecular imaging cellular function or molecular processes are visualized, normally using biomarkers. While in anatomical imaging no marker is used and visualization is based on the intrinsic properties of the tissues and organs being observed, such as the attenuation of X-rays in the case of computed tomography, molecular imaging very often uses biomarkers labeled with bioluminescence or fluorescence.
The global market for In Vivo Optical Imaging Systems was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for In Vivo Optical Imaging Systems was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vivo Optical Imaging Systems was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for In Vivo Optical Imaging Systems was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of In Vivo Optical Imaging Systems include Revvity, Berthold Technologies, Analytik Jena, Azure Biosystems, LICORBio, Vieworks, Ningbo Icoe Commodity, Canon Medical Systems, Sunny Optical Technology, Photon, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for In Vivo Optical Imaging Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of In Vivo Optical Imaging Systems by region & country, by Type, and by Application.
The In Vivo Optical Imaging Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Optical Imaging Systems.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of In Vivo Optical Imaging Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of In Vivo Optical Imaging Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of In Vivo Optical Imaging Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 In Vivo Optical Imaging Systems Product Introduction
1.2 Global In Vivo Optical Imaging Systems Market Size Forecast
1.2.1 Global In Vivo Optical Imaging Systems Sales Value (2019-2030)
1.2.2 Global In Vivo Optical Imaging Systems Sales Volume (2019-2030)
1.2.3 Global In Vivo Optical Imaging Systems Sales Price (2019-2030)
1.3 In Vivo Optical Imaging Systems Market Trends & Drivers
1.3.1 In Vivo Optical Imaging Systems Industry Trends
1.3.2 In Vivo Optical Imaging Systems Market Drivers & Opportunity
1.3.3 In Vivo Optical Imaging Systems Market Challenges
1.3.4 In Vivo Optical Imaging Systems Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global In Vivo Optical Imaging Systems Players Revenue Ranking (2023)
2.2 Global In Vivo Optical Imaging Systems Revenue by Company (2019-2024)
2.3 Global In Vivo Optical Imaging Systems Players Sales Volume Ranking (2023)
2.4 Global In Vivo Optical Imaging Systems Sales Volume by Company Players (2019-2024)
2.5 Global In Vivo Optical Imaging Systems Average Price by Company (2019-2024)
2.6 Key Manufacturers In Vivo Optical Imaging Systems Manufacturing Base and Headquarters
2.7 Key Manufacturers In Vivo Optical Imaging Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of In Vivo Optical Imaging Systems
2.9 In Vivo Optical Imaging Systems Market Competitive Analysis
2.9.1 In Vivo Optical Imaging Systems Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by In Vivo Optical Imaging Systems Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Optical Imaging Systems as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bioluminescence
3.1.2 Fluorescence
3.2 Global In Vivo Optical Imaging Systems Sales Value by Type
3.2.1 Global In Vivo Optical Imaging Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global In Vivo Optical Imaging Systems Sales Value, by Type (2019-2030)
3.2.3 Global In Vivo Optical Imaging Systems Sales Value, by Type (%) (2019-2030)
3.3 Global In Vivo Optical Imaging Systems Sales Volume by Type
3.3.1 Global In Vivo Optical Imaging Systems Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global In Vivo Optical Imaging Systems Sales Volume, by Type (2019-2030)
3.3.3 Global In Vivo Optical Imaging Systems Sales Volume, by Type (%) (2019-2030)
3.4 Global In Vivo Optical Imaging Systems Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratories
4.1.2 Vet Hospitals and Clinics
4.2 Global In Vivo Optical Imaging Systems Sales Value by Application
4.2.1 Global In Vivo Optical Imaging Systems Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global In Vivo Optical Imaging Systems Sales Value, by Application (2019-2030)
4.2.3 Global In Vivo Optical Imaging Systems Sales Value, by Application (%) (2019-2030)
4.3 Global In Vivo Optical Imaging Systems Sales Volume by Application
4.3.1 Global In Vivo Optical Imaging Systems Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global In Vivo Optical Imaging Systems Sales Volume, by Application (2019-2030)
4.3.3 Global In Vivo Optical Imaging Systems Sales Volume, by Application (%) (2019-2030)
4.4 Global In Vivo Optical Imaging Systems Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global In Vivo Optical Imaging Systems Sales Value by Region
5.1.1 Global In Vivo Optical Imaging Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global In Vivo Optical Imaging Systems Sales Value by Region (2019-2024)
5.1.3 Global In Vivo Optical Imaging Systems Sales Value by Region (2025-2030)
5.1.4 Global In Vivo Optical Imaging Systems Sales Value by Region (%), (2019-2030)
5.2 Global In Vivo Optical Imaging Systems Sales Volume by Region
5.2.1 Global In Vivo Optical Imaging Systems Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global In Vivo Optical Imaging Systems Sales Volume by Region (2019-2024)
5.2.3 Global In Vivo Optical Imaging Systems Sales Volume by Region (2025-2030)
5.2.4 Global In Vivo Optical Imaging Systems Sales Volume by Region (%), (2019-2030)
5.3 Global In Vivo Optical Imaging Systems Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America In Vivo Optical Imaging Systems Sales Value, 2019-2030
5.4.2 North America In Vivo Optical Imaging Systems Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe In Vivo Optical Imaging Systems Sales Value, 2019-2030
5.5.2 Europe In Vivo Optical Imaging Systems Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific In Vivo Optical Imaging Systems Sales Value, 2019-2030
5.6.2 Asia Pacific In Vivo Optical Imaging Systems Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America In Vivo Optical Imaging Systems Sales Value, 2019-2030
5.7.2 South America In Vivo Optical Imaging Systems Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa In Vivo Optical Imaging Systems Sales Value, 2019-2030
5.8.2 Middle East & Africa In Vivo Optical Imaging Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions In Vivo Optical Imaging Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions In Vivo Optical Imaging Systems Sales Value
6.2.1 Key Countries/Regions In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.2.2 Key Countries/Regions In Vivo Optical Imaging Systems Sales Volume, 2019-2030
6.3 United States
6.3.1 United States In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.3.2 United States In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.4.2 Europe In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.5.2 China In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.6.2 Japan In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.7.2 South Korea In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.8.2 Southeast Asia In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India In Vivo Optical Imaging Systems Sales Value, 2019-2030
6.9.2 India In Vivo Optical Imaging Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India In Vivo Optical Imaging Systems Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Revvity
7.1.1 Revvity Company Information
7.1.2 Revvity Introduction and Business Overview
7.1.3 Revvity In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Revvity In Vivo Optical Imaging Systems Product Offerings
7.1.5 Revvity Recent Development
7.2 Berthold Technologies
7.2.1 Berthold Technologies Company Information
7.2.2 Berthold Technologies Introduction and Business Overview
7.2.3 Berthold Technologies In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Berthold Technologies In Vivo Optical Imaging Systems Product Offerings
7.2.5 Berthold Technologies Recent Development
7.3 Analytik Jena
7.3.1 Analytik Jena Company Information
7.3.2 Analytik Jena Introduction and Business Overview
7.3.3 Analytik Jena In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Analytik Jena In Vivo Optical Imaging Systems Product Offerings
7.3.5 Analytik Jena Recent Development
7.4 Azure Biosystems
7.4.1 Azure Biosystems Company Information
7.4.2 Azure Biosystems Introduction and Business Overview
7.4.3 Azure Biosystems In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Azure Biosystems In Vivo Optical Imaging Systems Product Offerings
7.4.5 Azure Biosystems Recent Development
7.5 LICORBio
7.5.1 LICORBio Company Information
7.5.2 LICORBio Introduction and Business Overview
7.5.3 LICORBio In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 LICORBio In Vivo Optical Imaging Systems Product Offerings
7.5.5 LICORBio Recent Development
7.6 Vieworks
7.6.1 Vieworks Company Information
7.6.2 Vieworks Introduction and Business Overview
7.6.3 Vieworks In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Vieworks In Vivo Optical Imaging Systems Product Offerings
7.6.5 Vieworks Recent Development
7.7 Ningbo Icoe Commodity
7.7.1 Ningbo Icoe Commodity Company Information
7.7.2 Ningbo Icoe Commodity Introduction and Business Overview
7.7.3 Ningbo Icoe Commodity In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ningbo Icoe Commodity In Vivo Optical Imaging Systems Product Offerings
7.7.5 Ningbo Icoe Commodity Recent Development
7.8 Canon Medical Systems
7.8.1 Canon Medical Systems Company Information
7.8.2 Canon Medical Systems Introduction and Business Overview
7.8.3 Canon Medical Systems In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Canon Medical Systems In Vivo Optical Imaging Systems Product Offerings
7.8.5 Canon Medical Systems Recent Development
7.9 Sunny Optical Technology
7.9.1 Sunny Optical Technology Company Information
7.9.2 Sunny Optical Technology Introduction and Business Overview
7.9.3 Sunny Optical Technology In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Sunny Optical Technology In Vivo Optical Imaging Systems Product Offerings
7.9.5 Sunny Optical Technology Recent Development
7.10 Photon
7.10.1 Photon Company Information
7.10.2 Photon Introduction and Business Overview
7.10.3 Photon In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Photon In Vivo Optical Imaging Systems Product Offerings
7.10.5 Photon Recent Development
7.11 MILABS
7.11.1 MILABS Company Information
7.11.2 MILABS Introduction and Business Overview
7.11.3 MILABS In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 MILABS In Vivo Optical Imaging Systems Product Offerings
7.11.5 MILABS Recent Development
7.12 iThera Medical
7.12.1 iThera Medical Company Information
7.12.2 iThera Medical Introduction and Business Overview
7.12.3 iThera Medical In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 iThera Medical In Vivo Optical Imaging Systems Product Offerings
7.12.5 iThera Medical Recent Development
7.13 TOMOWAVE
7.13.1 TOMOWAVE Company Information
7.13.2 TOMOWAVE Introduction and Business Overview
7.13.3 TOMOWAVE In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 TOMOWAVE In Vivo Optical Imaging Systems Product Offerings
7.13.5 TOMOWAVE Recent Development
7.14 Clinx
7.14.1 Clinx Company Information
7.14.2 Clinx Introduction and Business Overview
7.14.3 Clinx In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Clinx In Vivo Optical Imaging Systems Product Offerings
7.14.5 Clinx Recent Development
7.15 Raylight Technology
7.15.1 Raylight Technology Company Information
7.15.2 Raylight Technology Introduction and Business Overview
7.15.3 Raylight Technology In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Raylight Technology In Vivo Optical Imaging Systems Product Offerings
7.15.5 Raylight Technology Recent Development
7.16 Tanon
7.16.1 Tanon Company Information
7.16.2 Tanon Introduction and Business Overview
7.16.3 Tanon In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Tanon In Vivo Optical Imaging Systems Product Offerings
7.16.5 Tanon Recent Development
7.17 Guangzhou Biolight Biotechnology
7.17.1 Guangzhou Biolight Biotechnology Company Information
7.17.2 Guangzhou Biolight Biotechnology Introduction and Business Overview
7.17.3 Guangzhou Biolight Biotechnology In Vivo Optical Imaging Systems Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Guangzhou Biolight Biotechnology In Vivo Optical Imaging Systems Product Offerings
7.17.5 Guangzhou Biolight Biotechnology Recent Development
8 Industry Chain Analysis
8.1 In Vivo Optical Imaging Systems Industrial Chain
8.2 In Vivo Optical Imaging Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 In Vivo Optical Imaging Systems Sales Model
8.5.2 Sales Channel
8.5.3 In Vivo Optical Imaging Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global In Vivo Optical Imaging Systems market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 176
USD 4900.00
(Single User License)
The global In Vivo Optical Imaging Systems market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 107
USD 4250.00
(Single User License)
The global market for In Vivo Optical Imaging Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 137
USD 3950.00
(Single User License)
The global In Vivo Optical Imaging Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 133
USD 2900.00
(Single User License)
The global In Vivo Optical Imaging Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 178
USD 4900.00
(Single User License)
The global In Vivo Optical Imaging Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 101
USD 4250.00
(Single User License)
The global market for In Vivo Optical Imaging Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 143
USD 3950.00
(Single User License)
The global market for In Vivo Optical Imaging Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
In vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. Generally speaking, this method can be divided in two key areas: anatomical/morphological imaging and molecular imaging. In molecular imaging cellular function or molecular processes are visualized, normally using biomarkers. While in anatomical imaging no marker is used and visualization is based on the intrinsic properties of the tissues and organs being observed, such as the attenuation of X-rays in the case of computed tomography, molecular imaging very often uses biomarkers labeled with bioluminescence or fluorescence.
Published Date: 2024-06-15
Pages: 153
USD 4350.00
(Single User License)
In vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. Generally speaking, this method can be divided in two key areas: anatomical/morphological imaging and molecular imaging. In molecular imaging cellular function or molecular processes are visualized, normally using biomarkers. While in anatomical imaging no marker is used and visualization is based on the intrinsic properties of the tissues and organs being observed, such as the attenuation of X-rays in the case of computed tomography, molecular imaging very often uses biomarkers labeled with bioluminescence or fluorescence.
Published Date: 2024-06-15
Pages: 171
USD 4900.00
(Single User License)
The global In Vivo Optical Imaging Systems market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 176
The global In Vivo Optical Imaging Systems market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 107
The global market for In Vivo Optical Imaging Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 137
The global In Vivo Optical Imaging Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 133
The global In Vivo Optical Imaging Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 178
The global In Vivo Optical Imaging Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 101
The global market for In Vivo Optical Imaging Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 143
The global market for In Vivo Optical Imaging Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 99
In vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. Generally speaking, this method can be divided in two key areas: anatomical/morphological imaging and molecular imaging. In molecular imaging cellular function or molecular processes are visualized, normally using biomarkers. While in anatomical imaging no marker is used and visualization is based on the intrinsic properties of the tissues and organs being observed, such as the attenuation of X-rays in the case of computed tomography, molecular imaging very often uses biomarkers labeled with bioluminescence or fluorescence.
Published: 2024-06-15
Pages: 153
In vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. Generally speaking, this method can be divided in two key areas: anatomical/morphological imaging and molecular imaging. In molecular imaging cellular function or molecular processes are visualized, normally using biomarkers. While in anatomical imaging no marker is used and visualization is based on the intrinsic properties of the tissues and organs being observed, such as the attenuation of X-rays in the case of computed tomography, molecular imaging very often uses biomarkers labeled with bioluminescence or fluorescence.
Published: 2024-06-15
Pages: 171
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now